Trials / Terminated
TerminatedNCT03207477
Premavision Cohort Follow-up
Visual Maturation in Prematurely Born Infants According to Factors Influencing Its Development. Premavision Follow-up at 18 Months Corrected Age, 4 and 7 Years of Age.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Months – 7 Years
- Healthy volunteers
- Accepted
Summary
This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251). In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Visual acuity measurement | visual acuity measurement by Baby Vision cards at 18 months corrected age, by Rossano Weiss test at 4 years of age and optometric tests of Parinaud and Snellen at 7 years of age |
Timeline
- Start date
- 2017-11-20
- Primary completion
- 2020-06-30
- Completion
- 2021-06-30
- First posted
- 2017-07-02
- Last updated
- 2021-08-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03207477. Inclusion in this directory is not an endorsement.